{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T12:47:17Z","timestamp":1785934037713,"version":"3.56.0"},"reference-count":17,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"unspecified","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Gastroenterol"],"accepted":{"date-parts":[[2026,6,1]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess industry payments to guideline authors, disclosure concordance with actual payments, and the auditability of conflict-of-interest governance in contemporary US gastroenterology and hepatology guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cross-sectional analysis of adult gastroenterology and hepatology guidelines published between 1 January 2019 and 31 December 2024, by the American Gastroenterological Association, American College of Gastroenterology, and American Association for the Study of Liver Diseases. Author disclosures were compared with manufacturer payments recorded in the Centers for Medicare and Medicaid Services Open Payments database during the 36 months preceding guideline acceptance or publication. Payments were considered relevant when originating from manufacturers of therapies recommended in the guideline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>13 guidelines, including 125 author appearances and 102 unique authors, met the inclusion criteria. 61 authors (48.8%) received at least one relevant manufacturer payment, with payments totalling US$1 733 865.58. Median payment among paid authors was US$9644.96. Disclosure discordance ranged from 0% to 85.7% across guidelines. Leadership roles were designated in 2 guidelines, and 4 of 13 met Institute of Medicine transparency standards.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Financial relationships between guideline authors and manufacturers of recommended therapies were common, and many guidelines lacked governance structures permitting external audit. Standardised leadership designation and transparent author-level disclosure may strengthen credibility of future guidelines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjgast-2026-002390","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:55:13Z","timestamp":1785930913000},"page":"e002390","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Industry payments and auditability of financial conflicts of interest in US gastroenterology and hepatology clinical practice guidelines: a cross-sectional analysis"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5962-885X","authenticated-orcid":false,"given":"Stephanie Hosanna","family":"Rodriguez","sequence":"first","affiliation":[{"name":"Internal Medicine, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Zhu","sequence":"additional","affiliation":[{"name":"Medical School, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Zhi","sequence":"additional","affiliation":[{"name":"Medical School, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Leventhal","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University of Minnesota Medical Center, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D","family":"Alpern","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA"},{"name":"Division of Infectious Diseases, Minneapolis VA Health Care System, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"2026080504550840000_13.1.e002390.1","unstructured":"Steinberg E , Greenfield S , Wolman DM , et al . Clinical practice guidelines we can trust. National Academies Press, 2011."},{"key":"2026080504550840000_13.1.e002390.2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-154-11-201106070-00011"},{"key":"2026080504550840000_13.1.e002390.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.156703"},{"key":"2026080504550840000_13.1.e002390.4","doi-asserted-by":"crossref","DOI":"10.1136\/fmch-2023-002437","article-title":"Trustworthy evidence-based versus untrustworthy guidelines: detecting the difference","volume":"11","author":"Lima","year":"2023","journal-title":"Fam Med Community Health"},{"key":"2026080504550840000_13.1.e002390.5","doi-asserted-by":"crossref","DOI":"10.1186\/s44158-023-00094-7","article-title":"How to recognize a trustworthy clinical practice guideline","volume":"3","author":"Lima","year":"2023","journal-title":"J Anesth Analg Crit Care"},{"key":"2026080504550840000_13.1.e002390.6","doi-asserted-by":"crossref","first-page":"111962","DOI":"10.1016\/j.jclinepi.2025.111962","article-title":"Trustworthiness of treatment clinical practice guidelines has modestly improved since the introduction of Institute of Medicine standards: a systematic survey","volume":"187","author":"Ghadimi","year":"2025","journal-title":"J Clin Epidemiol"},{"key":"2026080504550840000_13.1.e002390.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-018-5367-6"},{"key":"2026080504550840000_13.1.e002390.8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249267","article-title":"Analysis of conflict of interest policies among organizations producing clinical practice guidelines","volume":"16","author":"Brems","year":"2021","journal-title":"PLoS One"},{"key":"2026080504550840000_13.1.e002390.9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166485","article-title":"Policies on Conflicts of Interest in Health Care Guideline Development: A Cross-Sectional Analysis","volume":"11","author":"Morciano","year":"2016","journal-title":"PLoS One"},{"key":"2026080504550840000_13.1.e002390.10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.8592","article-title":"Conflicts of Interest Among Infectious Diseases Clinical Practice Guideline Authors and the Pharmaceutical Industry","volume":"6","author":"Ahiskali","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026080504550840000_13.1.e002390.11","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jamainternmed.2018.4730","article-title":"Evaluation of Industry Relationships Among Authors of Clinical Practice Guidelines in Gastroenterology","volume":"178","author":"Combs","year":"2018","journal-title":"JAMA Intern Med"},{"key":"2026080504550840000_13.1.e002390.12","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/ajg.2013.150","article-title":"Systematic analysis underlying the quality of the scientific evidence and conflicts of interest in gastroenterology practice guidelines","volume":"108","author":"Feuerstein","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"2026080504550840000_13.1.e002390.13","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.6343","article-title":"Assessment of Pharmaceutical Company and Device Manufacturer Payments to Gastroenterologists and Their Participation in Clinical Practice Guideline Panels","volume":"1","author":"Nusrat","year":"2018","journal-title":"JAMA Netw Open"},{"key":"2026080504550840000_13.1.e002390.14","unstructured":"International Committee of Medical Journal Editors . Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals. 2026."},{"key":"2026080504550840000_13.1.e002390.15","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-072252","article-title":"Managing risk from conflicts of interest in guideline development committees","volume":"379","author":"Parker","year":"2022","journal-title":"BMJ"},{"key":"2026080504550840000_13.1.e002390.16","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.200651"},{"key":"2026080504550840000_13.1.e002390.17","unstructured":"National Institute for Health and Care Excellence . Process and methods guides no.20. In: Developing NICE guidelines: the manual. London: National Institute for Health and Care Excellence (NICE), 2015."}],"container-title":["BMJ Open Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgast-2026-002390","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:55:15Z","timestamp":1785930915000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopengastro.bmj.com\/lookup\/doi\/10.1136\/bmjgast-2026-002390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,8,5]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/bmjgast-2026-002390"],"URL":"https:\/\/doi.org\/10.1136\/bmjgast-2026-002390","relation":{},"ISSN":["2054-4774"],"issn-type":[{"value":"2054-4774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}